主页文献库搜索
Multi-target modulation of the homologous recombination pathway by resveratro...

Yu(Z),Peng(W),Li(M),Li(F),Zhang(T),Nong(Y)... Int J Surg 2026-02-05

...BRCA1, and RAD51 - significantly enriched in the HR pathway. Molecular docking and dynamic simulations indicate that RSV...

The nuclease EXO1 promotes genomic instability by degrading nascent DNA in BR...

Nusawardhana(A),Nicolae(CM),Moldovan(GL) Nat Commun 2026-02-25

...BRCA1 and BRCA2 genes are observed in breast, ovarian, and other cancers. This results in defective homologous recombina...

Familial Disclosure and Cascade Testing in High-Risk Families is Influenced b...

Manirakiza(AVC),Freeman(JQ),Zhao(F),Keel(E... Res Sq 2026-05-05

...BRCA1: 39% and BRCA2: 18%) and 17.5% had moderate penetrance PVs; Rate of disclosure of PV to at least one family member...

Triple-negative breast cancer: current understanding and future perspectives.

Alobaidi(A),Rai(V) Explor Target Antitumor The... None

...BRCA1 mutation carriers. Standard management typically involves neoadjuvant chemotherapy followed by surgery and potenti...

PI3K/Akt/mTOR pathway expression profiling reveals age- and subtype-specific ...

Udobi(ME),Chinedu(SN),Afolabi(IS),Ezike(KN... Front Oncol None

...BRCA1 and BRCA2, alongside luminal regulators like GATA3, decline progressively with both advancing age and tumor aggres...

Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stag...

Gouveia(MC),Barroso-Sousa(R),Lapuchesky(L)... NPJ Breast Cancer 2026-03-03

...BRCA1/2 mutations, alongside a higher prevalence of impaired performance status. The pathologic complete response (pCR) ...

The Impact of Conventional Chemotherapy Regimens and Targeted Drugs on Ovaria...

Haskoylu(S),Sahin(SB),Altıntas(A),Yildiz(S... Reprod Sci 2026-04-00

...BRCA1/2 mutations may already exhibit reduced ovarian reserve and are more vulnerable to gonadal damage, possibly due to...

Reproductive Decision-Making Among BRCA1/2 Pathogenic Variants Carriers and P...

D'Alonzo(M),Actis(S),Lavalle(G),Suraci(S),... Prenat Diagn 2026-04-00

The objective of this paper is to investigate the knowledge and attitudes of BRCA1/2 pathogenic variant carriers and gyn...

Denosumab is associated with longer real-world progression-free survival in B...

Scafetta(R),Troiano(R),Gullotta(C),Guarino... Eur J Cancer 2026-05-15

...BRCA1/2 mutation status. Among 1399 patients, 46 harbored germline BRCA1/2 mutations (13 BRCA1, 33 BRCA2), and 21 of the...

Why are Some Tissues More Vulnerable? Revisiting Tissue Specificity in Heredi...

Kozak(VN),Oliveira(JC),Gradia(DF),Mathias(... Mol Diagn Ther 2026-07-00

...BRCA1, and BRCA2 and mismatch repair genes as the molecular explanations for familial clustering of specific cancer type...

上一页 50 51 52 53 54 55 56 57 58 下一页 54 / 共 1000

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com